CD4 and cancer: These results demonstrate that ATAC-seq-guided comparative analysis effectively identifies enriched chromatin signatures in breast cancer cfDNA data, and importantly, reveal that differential cfDNA enrichment is not limited to cancer cell specific open chromatin regions but also occurs at immune cell specific regions, such as those in CD4+ T cells.